Christopher Peetz, CEO: Mirum Pharmaceuticals MIRM Sell · Filed 25/03/18

Trade details

Type: Insider sale
Amount: $1,206,004.59
Shares · price: 27,279 sh · $44.21 a share
Held after: 138,641 sh
Stock: Mirum Pharmaceuticals MIRM
Person: Christopher PeetzCEO
Trade date: 25/03/17
Filed: 25/03/18
Days to filing: 1 days

Sold 16.4% of holdings

Share of holding sold: 16.4%

Mirum Pharmaceuticals trades, last 26 weeks

What else happened in Mirum Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 25/02/15~25/04/16

Christopher Peetz's recent trades

Christopher PeetzCEO
Planned sale10b5-1 planMirum Pharmaceuticals
Planned sale10b5-1 plan
Mirum Pharmaceuticals
MIRM
$3M
30,000 sh
$3M
Filed 09/01
Traded 09/01
Christopher PeetzCEO
Planned sale10b5-1 planMirum Pharmaceuticals
Planned sale10b5-1 plan
Mirum Pharmaceuticals
MIRM
$2M
20,000 sh
$2M
Filed 08/10
Traded 08/10
Christopher PeetzCEO
Planned sale10b5-1 planMirum Pharmaceuticals
Planned sale10b5-1 plan
Mirum Pharmaceuticals
MIRM
$2.4M
20,000 sh
$2.4M
Filed 07/06
Traded 07/06
Christopher PeetzCEO
Sell10b5-1 planMirum Pharmaceuticals
Sell10b5-1 plan
Mirum Pharmaceuticals
MIRM
$1.6M
16,595 sh
$1.6M
Filed 06/02
Traded 06/01
Christopher PeetzCEO
Sell10b5-1 planMirum Pharmaceuticals
Sell10b5-1 plan
Mirum Pharmaceuticals
MIRM
$665.9K
6,926 sh
$665.9K
Filed 06/02
Traded 06/01